PT Darya-Varia Laboratoria operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Darya-Varia Laboratoria with three other
pharmaceutical manufacturers in Asia:
Haw Par Corporation Limited
sales of 139.35 million Singapore Dollars [US$110.68 million]
of which 66%
was Healthcare Products),
I'rom Holdings Company Limited
(11.02 billion Japanese Yen [US$106.76 million]
of which 36%
was Manufacture and Sale of Pharmaceuticals), and
Harbin Gloria Pharmaceuticals Co., Ltd
based in China
(710.95 million Chinese Renmimbi [US$115.77 million]
of which 87%
was Injection Products).
PT Darya-Varia Laboratoria reported sales of 1.09 trillion Indonesian Rupiahs (US$112.00 million)
December of 2012.
increase of 11.8%
versus 2011, when the company's sales were 972.30 billion Indonesian Rupiahs.
Sales at PT Darya-Varia Laboratoria have increased during each of the previous five years
(and since 2007, sales have increased a total of 113%).
Sales of Toll Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
53.0% in 2012, from
129.42 billion Indonesian Rupiahs to 198.00 billion Indonesian Rupiahs.